Analysis on infection distribution and drug resistance of 499 strains Acinetobacter baumannii
HUANG Lu-ping
LIU Jun-hui
Abstract：Objective To investigate the distribution and drug resistant of Acinetobacter baumannii in our hospital, and to provide guidance for the reasonable use of antibiotic drugs in clinic. Methods 499 strains Acinetobacter baumannii from January 2013 to December 2015 in our hospital were collected , and the distri-bution and drug resistant were analyzed by WHONET 5.6 analyzer. Results 499 strains Acinetobacter bau-mannii were isolated, among which there were 158 strains in 2013(31.7%), 184 strains in 2014(36.8%), and 157 strains in 2015 (31.5%). The Acinetobacter baumannii mainly isolated from sputum (385 strains, 77.15%), and wound secreta (37 strains, 7.41%). While the top three clinics were ICU (136 strains, 27.25%), respiration medicine (110 strains, 22.04%) and neurosurgery (77 strains, 15.43%). The Acineto-bacter baumannii were high sensitive to tobramycin, then piperacillin and tazobactam, and imipenem. The rates of extensive drug resistance from 2013 to 2015 were 15.8%, 12.5%, and 26.8%. Conclusion Acineto-bacter baumannii is high resistance to antibiotic. Drug resistance surveillance should be strengthened to guide the clinical medication.
Keywords：Acinetobacter baumanniiNosocomial infectionAntibioticsExtensive drug resistance
Publication Date：2016-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 97-99 )